The Food and Drug Administration (FDA) is thinking to approve a second Covid-19 vaccine booster for people above 50 years of age amid concerns about a new Omicron subvariant that could hit the US. The authorisations for second Pfizer and Moderna boosters can be done by next Tuesday, according to media reports.
- Cabinet approves Rs 6,839 crore for Vibrant Villages Programme-II to boost border development
- ChatGPT Can Create Fake Aadhaar, PAN Cards—But Here’s Why It’s Not a Big Concern
- China to impose 34% additional tariff on all US goods from 10th April
- Rs 18,658 Crore Rail Network Boost to Strengthen Connectivity Across Three States
- Aerem Secures Rs 100 Crore Through Series A
Hawaii became the last US state to remove the indoor masking need as the Omicron cases reduced. The state also suspended its Safe Travels program and allowed travellers from other states to enter without giving proof of vaccination. Idaho also passed a bill to stop businesses from requiring a Covid-19 vaccination for employment or service and prevent unvaccinated individuals from being treated differently. According to the bill, to receive a vaccine or not is a very personal and individual decision and one that public or private sectors should not mandate.
